Apixax 2.5 mg
Apixax 2.5 mg is a medicine authorised by Swissmedic under authorisation number 70406. The authorisation holder is Drossapharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 May 2026 and the authorisation is limited until 25 May 2031. ATC code B01AF02 places the medicine in the group Antithrombotic agents.
| Authorisation number | 70406 |
|---|---|
| Name | Apixax 2.5 mg |
| Full name | Apixax 2.5 mg, Filmtabletten |
| Authorisation holder | Drossapharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AF02 |
| First authorisation | 26 May 2026 |
| Authorisation validity | 25 May 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Apixax 2.5 mg, Filmtabletten | B | 26 May 2026 |
| 2 | Apixax 5 mg, Filmtabletten | B | 26 May 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 2 | 56 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 3 | 100 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 4 | 168 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 5 | 56 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 6 | 100 | Tablette(n) | B01AF02 | 06.03.0. | B |
| 7 | 168 | Tablette(n) | B01AF02 | 06.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Apixax 2.5 mg authorised in Switzerland?
Yes. Apixax 2.5 mg is authorised by Swissmedic under authorisation number 70406, data as of 01 September 2026. The authorisation is limited until 25 May 2031.
Which dispensing category does Apixax 2.5 mg have?
Apixax 2.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Apixax 2.5 mg?
The authorisation holder is Drossapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.